Cognitive performance, neuropsychiatric symptoms, and cerebrospinal fluid viral control following programmatic switch from efavirenz-based to dolutegravir-based antiretroviral therapy in South Africa (CONNECT): a prospective cohort study
Sam Nightingale, Anna J. Dreyer, Kevin G. F. Thomas, Gert U. van Zyl, Eric Decloedt, Petrus J.W. Naudé, Catherine Orrell, Phumla Sinxadi, Alan Winston, Saye Khoo, John A. Joska
Topics & Concepts
DolutegravirMedicineEfavirenzAntiretroviral therapyProspective cohort studyHuman immunodeficiency virus (HIV)CohortANTIRETROVIRAL AGENTSCerebrospinal fluidCohort studyPsychiatryVirologyPediatricsViral loadInternal medicineHIV/AIDS drug development and treatmentHIV Research and TreatmentHIV/AIDS Research and Interventions